Last updated: 22 July 2019 at 4:11pm EST

Samuel J Moed Net Worth




The estimated Net Worth of Samuel J Moed is at least $3.73 Million dollars as of 13 March 2015. Samuel Moed owns over 591 units of Bristol-Myers Squibb Co stock worth over $1,506,970 and over the last 12 years Samuel sold BMY stock worth over $2,220,403.

Samuel Moed BMY stock SEC Form 4 insiders trading

Samuel has made over 16 trades of the Bristol-Myers Squibb Co stock since 2013, according to the Form 4 filled with the SEC. Most recently Samuel sold 591 units of BMY stock worth $39,402 on 13 March 2015.

The largest trade Samuel's ever made was exercising 60,100 units of Bristol-Myers Squibb Co stock on 4 June 2013 worth over $1,544,570. On average, Samuel trades about 10,159 units every 41 days since 2013. As of 13 March 2015 Samuel still owns at least 31,014 units of Bristol-Myers Squibb Co stock.

You can see the complete history of Samuel Moed stock trades at the bottom of the page.



What's Samuel Moed's mailing address?

Samuel's mailing address filed with the SEC is BRISTOL-MYERS SQUIBB COMPANY, 345 PARK AVENUE, NEW YORK, NY, 10154.

Insiders trading at Bristol-Myers Squibb Co

Over the last 17 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius, and Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.



What does Bristol-Myers Squibb Co do?

The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.



Complete history of Samuel Moed stock trades at Bristol-Myers Squibb Co

Insider
Trans.
Transaction
 Total value
Samuel J Moed
SVP, Strat Plan, and Analysis
 Sale $39,402
13 Mar 2015
Samuel J Moed
SVP, Strat Plan, and Analysis
 Sale $680,983
10 Mar 2015
Samuel J Moed
SVP, Strat Plan, and Analysis
 Option $67,920
6 Mar 2015
Samuel J Moed
SVP, Strat Plan, and Analysis
 Option $513,913
2 Mar 2015
Samuel J Moed
SVP, Strat Plan, and Analysis
 Option $73,140
2 Mar 2015
Samuel J Moed
SVP, Strat Plan, and Analysis
 Sale $229,929
12 Feb 2015
Samuel J Moed
SVP, Strat Plan, and Analysis
 Option $618,547
6 Feb 2015
Samuel J Moed
SVP, Strat Plan, and Analysis
 Sale $1,270,089
28 Jul 2014
Samuel J Moed
SVP, Strat Plan, and Analysis
 Option $247,600
1 May 2014
Samuel J Moed
SVP, Strat Plan, and Analysis
 Option $65,852
10 Mar 2014
Samuel J Moed
SVP, Strat Plan, and Analysis
 Option $57,949
6 Mar 2014
Samuel J Moed
SVP, Strat Plan, and Analysis
 Option $813,529
3 Mar 2014
Samuel J Moed
SVP, Strat Plan, and Analysis
 Option $1,544,570
4 Jun 2013
Samuel J Moed
SVP, Strat Plan, and Analysis
 Option $198,600
1 May 2013
Samuel J Moed
SVP, Strat Plan, and Analysis
 Option $541,370
7 Mar 2013
Samuel J Moed
SVP, Strat Plan, and Analysis
 Option $71,922
3 Mar 2013


Bristol-Myers Squibb Co executives and stock owners

Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: